An innovative approach for locally advanced stage III cutaneous melanoma: Radiotherapy, followed by nodal dissection

Melanoma Research

Volumn 22, Issue 3, 2012, Pages 257-262

  Foote, Matthew ^a   Burmeister, Bryan ^a   Dwyer, Patrick ^a   Burmeister, Elizabeth ^e   Lambie, Duncan ^c   Allan, Christopher ^c   Barbour, Andrew ^a   Bayley, Gerard ^f   Pullar, Andrew ^a,d   Meakin, Janelle ^f   Thomas, Janine ^b   Smithers, Mark ^b  

^a Department of Radiation Oncology ^*  (Australia)

^b Queensland Melanoma Project   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^e GRIFFITH UNIVERSITY   (Australia)

^f MATER ADULT HOSPITAL   (Australia)

Author keywords

Bulky; Melanoma; Nodal; Preoperative; Radiotherapy; Stage III

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AXILLA; CANCER CONTROL; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALE; MELANOMA; MORBIDITY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECURRENCE FREE SURVIVAL; SURGICAL WOUND; TREATMENT RESPONSE;

ADULT; AGED; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; QUEENSLAND; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84860763659     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3283531335     Document Type: Article

References (19)

1. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007; 82: 364-380. (Pubitemid 46348938)
2. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet 2005; 365:687-701. (Pubitemid 40260892)
3. Edge SB. American Joint Committee on Cancer. AJCC cancer staging manual. New York: Springer 2010.
4. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989; 124:1051-1055. (Pubitemid 19231243)
5. Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia C, Kraybill WG. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2000; 46:467-474. (Pubitemid 30067798)
6. Miller EJ, Daly JM, Synnestvedt M, Schultz D, Elder D, Guerry D IV. Loco-regional nodal relapse in melanoma. Surg Oncol 1992; 1:333-340.
7. Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB. Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines. J Clin Oncol 2010; 28:3042-3047.
8. Burmeister B, Henderson M, Thompson J, Fisher R, Di Iulio J, Smithers M, et al. Adjuvant radiotherapy improved regional (lymph node field) control in melanoma patients after lymphadenectomy: results of an intergroup randomized trial (TROG 02. 01/ANZMTG 01. 02). Int J Radiat Oncol Biol Phys 2009; 75:S2.
9. Porceddu SV, Pryor DI, Burmeister E, Burmeister BH, Poulsen MG, Foote M, et al. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head Neck 2011; 33:1675-1682.
10. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6:659-668. (Pubitemid 41222756)
11. O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002; 359:2235-2241. (Pubitemid 34717977)
12. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731-1740.
13. Burmeister BH, Mark Smithers B, Burmeister E, Baumann K, Davis S, Krawitz H, et al. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) Study 96. 06. Radiother Oncol 2006; 81:136-142. (Pubitemid 44708373)
14. Burmeister BH, Smithers BM, Poulsen M, McLeod GR, Bryant G, Tripcony L, Thorpe C. Radiation therapy for nodal disease in malignant melanoma. World J Surg 1995; 19:369-371.
15. Corry J, Smith JG, Bishop M, Ainslie J. Nodal radiation therapy for metastatic melanoma. Int J Radiat Oncol Biol Phys 1999; 44:1065-1069. (Pubitemid 29342908)
16. Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, et al. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 2006; 64:106-113. (Pubitemid 41831216)
17. Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, et al. Prospective comparison of [18F]-fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. J Clin Oncol 2009; 27: 4774-4780.
18. Kruijff S, Bastiaannet E, Speijers MJ, Kobold AC, Brouwers AH, Hoekstra HJ. The value of pre operative S-100B and SUV in clinically stage III melanoma patients undergoing therapeutic lymph node dissection. Eur J Surg Oncol 2011; 37:225-232.
19. Shada AL, Walters DM, Tierney SN, Slingluff CL Jr. Surgical resection for bulky or recurrent axillary metastatic melanoma. J Surg Oncol 2012; 105:21-25.